Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Swedish Orphan Biovitrum AB (SOBI SS)
Watchlist
4
Analysis
Health Care
•
Sweden
Swedish Orphan Biovitrum AB (SOBI) operates as a bio-pharmaceutical and bio-technology company. The Company develops therapies and drugs for the treatment of haemophilia, inflammation, and genetic diseases. SOBI serves clients worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Petroleo Brasileiro
•
06 Jan 2024 03:50
Buys Within Global Energy, Health Care, and Utilities; Bullish Outlook Intact on Global Equities
Seeing a clear shift into value and defensives, and we recommend adding exposure to these areas globally. Constructive if supports hold: $98-99 on...
Vermilion Research
Follow
419 Views
Share
bullish
•
Swedish Orphan Biovitrum AB
•
13 Sep 2021 03:22
Advent & GIC/SOBI: Awaiting a Sweetened Offer
Median implied valuation across multiples is SEK 246.71/share, c. 5% above offer price. I believe that the offer from the bidding consortium may be...
Jesus Rodriguez Aguilar
Follow
261 Views
Share
bullish
•
MSCI ACWI Index
•
20 Feb 2020 07:53
Global Equity Strategy: Buy the Dips
Despite recent weakness across global markets, our weight of the evidence approach continues to lead us to the same conclusions as we posited in...
Vermilion Research
Follow
407 Views
Share
bullish
•
MSCI World Index
•
24 Jul 2018 04:25
Global Equity Strategy: Where to Hide Outside the U.S.
The U.S. has continued to separate itself from broad emerging market and developed international indexes. One positive is that MSCI EM and MSCI...
Vermilion Research
Follow
474 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.1
x